HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability by unknown
Zhao et al. Journal of Experimental & Clinical Cancer Research  (2016) 35:180 
DOI 10.1186/s13046-016-0454-4RESEARCH Open AccessHPV16 integration probably contributes to
cervical oncogenesis through interrupting
tumor suppressor genes and inducing
chromosome instability
Jun-Wei Zhao1†, Fang Fang1†, Yi Guo1, Tai-Lin Zhu2, Yun-Yun Yu1, Fan-Fei Kong1, Ling-Fei Han1,
Dong-Sheng Chen3,4* and Fang Li1*Abstract
Background: The integration of human papilloma virus (HPV) into host genome is one of the critical steps that
lead to the progression of precancerous lesion into cancer. However, the mechanisms and consequences of such
integration events are poorly understood. This study aims to explore those questions by studying high risk HPV16
integration in women with cervical intraepithelial neoplasia (CIN) and cervical squamous cell carcinoma (SCC).
Methods: Specifically, HPV integration status of 13 HPV16-infected patients were investigated by ligation-mediated
PCR (DIPS-PCR) followed by DNA sequencing.
Results: In total, 8 HPV16 integration sites were identified inside or around genes associated with cancer
development. In particular, the well-studied tumor suppressor genes SCAI was found to be integrated by HPV16,
which would likely disrupt its expression and therefore facilitate the migration of tumor. On top of that, we
observed several cases of chromosome translocation events coincide with HPV integration, which suggests the
existence of chromosome instability. Additionally, short overlapping sequences were observed between viral
derived and host derived fragments in viral-cellular junctions, indicating that integration was mediated by micro
homology-mediated DNA repair pathway.
Conclusions: Overall, our study suggests a model in which HPV16 might contribute to oncogenesis not only by
disrupting tumor suppressor genes, but also by inducing chromosome instability.
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Cervical cancer is one of the most common types of
cancer in women around the world. HPV types 16 and
18 are predominant genotypes leading to cervical cancer,
while other genotypes such as HPV 31, 45 and 58 are
mainly associated with intra-epithelial and cancerous
lesions [1, 2]. Although HPV16 and 18 are considered to
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common genotype in Asian countries and our previous
results suggested that HPV16 and 52, instead of HPV18,
are the top two prevalent types in Shanghai women
[3–6]. The viral DNA is usually found to integrate
into the host genome with subsequent disruption of
one or more viral open reading frames (ORFs) [7].
HPV integration frequently disrupts in the E1 and/or
E2 ORFs. Luft, F. et al. reported that the viral E1
open reading frame (ORF) was fused to cellular
sequences in 20 of 22 cases [8]. Interestingly, recent
study suggests that HPV16 could establish latent
infection in morphologically normal women [9]. By
now, most of the research about HPV integrationle is distributed under the terms of the Creative Commons Attribution 4.0
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which left the integration of viral fragments in CIN
or SCC patients largely unexplored. Besides, the dis-
tribution characteristics about the HPV integration
sites in the host genomes are not fully understood,
and the study on mechanisms by which HPV inte-
grated into human genes is still in its infancy. In this
study, we focus on integration sites analysis of
HPV16, the most common types of HPV in Shanghai,
trying to understand the HPV16 integration character-
istics and the potential consequence of viral fragment
integration.
In a systematic analysis on more than 1500 integration
sites of HPV collected from literature, Bodelon and col-
leagues found integration events were enriched in 10
cytobands (3q28, 8q24.21 and 13q22.1,2q22.3, 3p14.2,
8q24.22, 14q24.1, 17p11.1, 17q23.1 and 17q23.2). Be-
sides, they noticed that there was significantly higher
chance for HPV18 to be integrated in 8q24.21 than
HPV16 in Cervical infections (p = 6.93e-9). Based on the
observation that integration sites were closely linked to
transcriptionally active regions, fragile sites, CpG re-
gions, and enhancers, they proposed that HPV tend to
integrate in open chromatin regions, which might affect
the transcription of corresponding genes. Another inter-
esting finding in their study was that HPV integration
events rarely occurred in the vicinity of known cervical
cancer driver genes (within 50 Kb) [10].
Methods
Clinical samples collection
Cast-off cells of end cervical tissues were obtained from
patients using cell brush in Cervical Disease Centre of
Shanghai First Maternity and Infant Health Hospital,
TongJi University School of Medicine (Shanghai, China).
Genomic DNA extraction
Genomic DNA from cervical cell brush samples was
purified by silica gel columns (TIANamp Genomic DNA
Kit No: 3304–9; TIANGEN Biotech Corporation, China)
according to the manufacturer’s procedure. Final elution
of DNA was resuspended in 50 μl of distilled water. And
the DNA samples with concentration greater than
80 ng/μl were used to detect the HPV16 integration sites
by DIPS-PCR.
DIPS-PCR
The DIPS-PCR was performed following the protocol in
Luft F et al’s paper [8].
Sequencing
PCR products were excised from an agarose gel, purified.
Subsequently, direct sequencing was performed bySAIYIN gene biotechnology company (SaiYin gene bio-
technology company, Shanghai, China).
Mapping of viral and cellular sequences in viral-cellular
junctions
The whole junction sequences were blast against NCBI
HPV16 (taxid: 333760) database, the option ‘Somewhat
similar sequences (blastn)’ was used. The part of se-
quences with alignment with HPV sequences were anno-
tated as viral sequences. Subsequently, the whole
junction sequences were blasted against Ensemble data-
base (GRCh38) using the blastn tool and with search
sensitivity ‘distant homologies’. The aligned sequences
with human reference genome were annotated as cellu-
lar sequence.
Extract of gene lists around HPV integration sites
The locations of cellular fragments were obtained by
manually checking the blast result. In Ensemble Biomart
[11], all the protein encoding genes within certain dis-
tances (1 mega bases or 10 mega bases) from HPV16 in-
tegration center were downloaded for further analysis.
GO enrichment analysis of gene lists
GO enrichment was performed using Gorilla [12], with
the option ‘two unranked lists of genes (target and back-
ground lists)’. The background gene list (all protein cod-
ing genes in human) was downloaded from Ensemble
database. FDR method was used to calculate the ad-
justed P value.
Protein interaction network analysis
Those genes directly overlapped with HPV integrating
sites were searched in STRING database [13] one by
one. The protein interaction networks acquired from
STRING were downloaded for further analysis.
Hi-C data analysis
The chromosome interaction data of GM12878 was
downloaded from the Interactive Hi-C Data Browser [14].
Results
Overview of viral-cellular junctions in 13 patients infected
with HPV16
In this study, 13 DNA samples from HPV16 positive pa-
tients with different grades of cervical neoplasia and cer-
vical cancer were analyzed using ligation-mediated PCR
(DIPS-PCR) combined with Sanger sequencing (Table 1).
In total, 6 out of 13 samples were found to be integrated
by HPV16 in cellular genome. Specifically, two integra-
tion sites were identified in samples S2-25 and C5-87 re-
spectively. One integration site was found in each of the
remaining 4 samples (S1-2, C3-64, C4-77 and S6-95).
Table 1 The samples collected from HPV positive patients
Sample name Age (years) Pathology Number of validated
viral-cellular junctions
S1-2 41 SCC 1
S2-25 45 HSIL 2
C3-64 45 HSIL 1
C4-77 32 HSIL 1
C5-87 49 HSIL 2
S6-95 48 SCC 1
C7-35 44 Normal 0
C8-7 51 HSIL 0
S9-10 38 SCC 0
S10-11 43 SCC 0
C11-60 28 HSIL 0
C12-67 42 SCC 0
C13-75 35 LSIL 0
HSIL: high-grade squamous intraepithelial lesion, LSIL: low grade squamous
intraepithelial lesion, SCC: squamous cell carcinoma. The sample ID, age of
pateints, Pathology of patients and number of validated viral-cellular junctions
in each sample were shown in column 1, 2, 3 and 4 respectively
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In total, there are 8 viral-cellular junctions were identi-
fied from those 6 samples (Table 2 and Additional file 1:
File S1). For the sake of clarity, each junction was
assigned an unique ID such as ‘S1-2:J-01’ which begins
with sample number and follows by junction number.
Those 8 junctions can be divided into type 1 junctionsTable 2 Overview of architectures of 8 viral-cellular junctions




S1-2:J-01 Type 2 HPV16 E1(211 bp) NA
S2-25:J-03 Type 1 HPV16 E1(122 bp) chr
125
SCA
S2-25:J-04 Type 1 HPV16 E1(185 bp) chr
307
C3-64:J-05 Type 2 HPV16 E2(325 bp) NA
C4-77:J-06 Type 2 chr4:185352615-
185352687 SNX25(72 bp)
NA
C5-87:J-07 Type 2 chr22:34824077-34824170(93 bp) NA




S6-95:J-09 Type 2 HPV16 E1(239 bp) NA
Each viral-cellular junction was assigned an unique ID. 8 junctions were divided
1: 3-element junction with the architecture of virus-human-human or human-human-v
virus. The origin of each elements were shown in column 3, 4 and 5 respectively. The o
available(S2-25:J-03, S2-25:J-04 and C5-87:J-08) and type 2 junc-
tions (S1-2:J-01, C3-64:J-05, C4-77:J-06, C5-87:J-07 and
S6-95:J-09). Type 1 junctions are 3-element chimera
with the architecture of virus-human-human or human-
human-virus, while type 2 junctions are 2-element
chimera with the architecture of virus-human or
human-virus (Table 2).
Cellular genes directly overlapping with viral-cellular
junctions
S1-2:J-01 belongs to type 2 junction (virus-human), with
a 211 base pairs (bp) left element from HPV16 E1 gene
and a 63 bp right element from chromosome 3 located
in the intron of N-acetyl-l-aspartyl-l-glutamate
peptidase-like 2 (NAALADL2). S2-25:J-03 belongs to
type 1 junction (virus-human-human), with the left
element from HPV16 E1 gene (122 bp), middle element
from chromosome 9 (261 bp) overlapped with suppres-
sor of cancer cell invasion (SCAI) gene and the right
element from chromosome 4 (159 bp) overlapping with
Nuclear Receptor Subfamily 3, Group C, Member 2
(NR3C2) gene. Six nt (GATGCA) were overlapped be-
tween left viral element and middle cellular element
while four nt (GATC) were found to be overlapped be-
tween middle and right cellular elements.S2-25:J-04 is a
type 1 junction (virus-human-human), composed of
HPV16 E1 gene (185 bp) flowed by chromosome 17
(93 bp) and chromosome 1 (322 bp). No overlapping
















Left & Middle: GATGCA











Left & Right: AA
HPV16 L1(310 bp) Left & Right: No
overlapping
HPV16 L1(224 bp) Left & Right: CAATA
X:109333446-
333511(66 bp)
HPV16 E5 (299 bp) Left & Middle: GTGG




Left & Right: CTGCAA
into 2 types according to the architecture of viral-cellular junctions. Type
irus. Type 2: 2-element junction with the architecture of virus-human or human-
verlapping between every two elements were shown in column 6. NA, not
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(325 bp) in the left, chromosome 3 (189 bp) in the right,
located in the intron of Kalirin, RhoGEF Kinase
(KALRN). Two nt (AA) were found in those two ele-
ments.C4-77:J-06 belongs to type 2 junction (human-
virus) with the left element from chromosome 4 (72 bp)
overlapping with SNX25 and right element from HPV16
L1 gene (310 bp). No overlapping was found in this
junction. C5-87: J-07 belongs to type 2 junction (human-
virus) composed of chromosome 22 (93 bp) and HPV16
L1 gene (224 bp) with left and right elements overlap by
5 nt (CAATA). C5-87: J-08 is a type 1 junction (human-
human-virus) with chromosome 22 (201 bp) in the left,
followed by chromosome X (66 bp) and HPV16 E5&L2
gene (299 bp). The left and middle element overlap by
four nt (GTGG) while middle and right element overlap
by five nt (GTGTT). S6-95: J-09 is a type 2 junction
(virus-human) composed of HPV16 E1 gene (239 bp)
and chromosome 16 (159 bp) which directly overlap
with the intron of Cadherin 13 (CDH13). Six nt
(CTGCAA) were found to be overlapped between left
viral and right cellular fragments.
Cellular genes located around HPV16 integration sites
Among the 8 integration events, 5 are directly over-
lapped with the intron region of protein encoding genes
(NAALADL2, SCAI, KALRN, SNX25, CDH13). Others
are located in intergenic regions of protein coding genes.
To investigate those genes around integrating sites, we
extracted all genes located within 1 mega bases and 10
mega bases from the integrating site center. They were
called G1 and G10 data sets, and 58 and 758 protein en-
coding genes were found in those two data sets respect-
ively (Additional file 1: Tables S1 and S2). After that, we
performed Gene Ontology (GO) enrichment analysis to
reveal the potential biological process affected by
HPV16 integration. Our result suggested that there were
no enriched GO terms in G1 data set while 5 GO terms
were found to be enriched with adjusted p value (FDR
correction) smaller than 0.05 in G10 data set (Table 3).
Interestingly, they are related to the transfer of genetic
materials (GO:0010528 regulation of transposition), the
migration of tumor (GO:0002548 monocyte chemo-
taxis), immune response (GO:0071346 cellular response
to interferon-gamma and GO:0034341 response to
interferon-gamma) and DNA repair (GO:0070383 DNA
cytosine deamination).
Common fragile sites located around HPV16 integrating
sites
Chromosomal fragile sites are unstable chromosome re-
gions that are prone to breakage under replication stress
[15]. Fragile sites can be classified into ‘rare’ and ‘com-
mon’ ones based on the frequencies of those sitesappearing in population. Common fragile sites (CFSs)
are those present in almost all individuals. By now, more
than 120 CFSs have been identified from human chro-
mosomes [15, 16]. We compared the 8 HPV16 integra-
tion sites with those known CFSs and found that 11
CFSs have been to found to be located around HPV16
integration sites (Table 4).
Chromosome translocation around HPV16 integration
sites
Among the 8 integrating sites identified in this study, 3
of them are found to coincide with chromosome trans-
location. In the case of S2-25: J-03, we observed the
translocation between chromosome 9 and chromosome
4. In S2-25: J-04, the translocation happened between
chromosome 17 and chromosome 1. In C5-87: J-08, we
identified another translocation event which happened
between chromosome 22 and chromosome X (Fig. 1).
HPV affected cancer-related genes documented in Dr.VIS
v2.0 database
In order to address the HPV affected cancer-related
genes at a larger scale, we downloaded the annotation of
HPV integration events from Dr.VIS v2.0 database. After
filtering out records without gene annotation and those
missing the information of distance between integration
sites and nearest gene, 343 well-annotated records were
left for further analysis. By checking the gene list manu-
ally, we found several cancer related genes integrated by
HPV either in the intron or 5’ flanking region (Table 5),
they were TNFSF4 (tumor necrosis factor superfamily
member 4), TP63 (tumor protein p63), TP73 (tumor pro-
tein p73), ARHGEF4 (Rho guanine nucleotide exchange
factor 4), CDH13 (cadherin 13), RASSF6 (Ras association
domain family member 6) [17–30].
Variability of inserted HPV fragments
In this study, we analyzed the variability of inserted HPV
fragments, and found they showed a range of variability
compared to the reference HPV16 strains. Briefly, the
inserted viral elements were searched against NCBI
database [31–33] and the alignment between the viral
sequences and HPV16 sequences were checked manually
to investigate the variability (Fig. 2 and Additional file 2:
Figure S1). Among the 8 viral elements, 4 viral elements
derived from E1 gene, 2 from L1 gene, 1 from E2 gene
and 1 from E5 gene.
S1-2:J-01-F-01-virus-left was found to be most similar
to the E1 gene of HPV16 strain A24645 (GenBank:
JQ791080.1). There were 12 nucleotides of deletions, 8
nucleotides of insertions and 11 nucleotides of mis-
matches. Notably, there was a insertion consisting of 7
consecutive nucleotides and a deletion comprising of 9
consecutive nucleotides in S1-2:J-01-F-01-virus-left.
Table 3 Enriched GO terms in G10 data sets (758 genes which are located with 10 mega from the HPV16 integration sites)
GOterm Description P-value FDR q-value
GO:0010528 Regulation of transposition 1.37E-07 1.92E-03
GO:0002548 Monocyte chemotaxis 6.18E-07 2.88E-03
GO:0071346 Cellular response to interferon-gamma 1.47E-06 5.14E-03
GO:0034341 Response to interferon-gamma 4.00E-06 1.12E-02
GO:0070383 DNA cytosine deamination 1.47E-05 3.44E-02
The ID, description, P-value and FDR q-value (adjusted P value) were shown in column 1, 2, 3 and 4 respectively
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E1 gene of HPV16 strain (GenBank: NC_001526.4). One
nucleotide deletion was found in S2-25:J-03-F-03-virus-
left compared to E1 gene of HPV16 (NC_001526.4).
S2-25:J-04-virus-left was most similar to the E1 gene
of HPV16 strain NC_001526.4. One nucleotide deletion
and one nucleotide mismatch was found in S2-25:J-03-
F-03-virus-left compared to E1 gene of the reference
HPV (NC_001526.4).
C3-64:J-05-virus-left most resembled the E2 gene of
HPV16 isolate D15 (HM162476). 2 nucleotides of dele-
tions, 2 nucleotides of insertions and 3 nucleotides of
mismatches were found in C3-64:J-05-virus-left com-
pared to E1 gene of the reference HPV16 isolate D15.
C4-77:J-06-virus-right was more similar to the L1 gene
of HPV16 strain KU951195.1 than that any other pub-
lished HPV strains. Single nucleotide deletion was found
in C4-77:J-06-virus-right compared to L1 gene of the
HPV16 strain KU951195.1.
C5-87:J-07-virus-right was most similar to the L1 gene
of HPV16 isolate 16CN46 (GenBank: KU951194.1).
100% identity was found between C5-87:J-07-virus-right
and L1 gene of HPV16 isolate 16CN46, without any de-
letion, insertion or mismatch.
C5-87:J-08-virus-right was 100% identical to the
corresponding region of E5 gene of HPV16 isolate 16-
Anhui12 from China (GenBank: KC935953.1). Again, no
deletion, insertion or mismatch were detected.Table 4 The CFSs located around HPV16 integration sites
Junction ID Integrating location Nearest CFSs
S1-2:J-01 3q26.31 FRA3C(3q27)
S2-25:J-03 9q33.3 and 4q31.22 FRA9E(9q32) and FRA4C(4q31.1)




C5-87:J-08 22q12.3 and Xq23 FRA22B(22q12.2) and FRAXD(Xq27)
S6-95:J-09 16q23.3 FRA16D(16q23)
The junction ID, integrating location in the chromosome (shown as
cytobands), nearest common fragile sites (CFSs) to the integration sites were
shown in column 1, 2 and 3 respectivelyS6-95:J-09-virus-left was most closely related to the E1
gene of HPV16 isolate (GenBank: NC_001526). A dele-
tion comprising of single nucleotide and a deletion con-
sisting of 4 consecutive nucleotide were discovered in
S6-95:J-09-virus-left, compared to the E1 gene of HPV16
isolate (NC_001526).
Discussion
Variability of inserted viral fragments and possible
outcomes of viral mutation
HPV were reported to exist in 2 forms: free episomes in
the nucleus or integrated form in the cells genome. The
transition from high-grade cervical intraepithelial neo-
plasia to micro-invasive carcinoma has been proposed to
be characterized by the integration of HPV 16/18 [34].
The E2 protein is a transcriptional regulator for viral
promoters located in the long control region, which
negatively regulates the expression level of viral onco-
genes (E6 and E7) [35, 36]. The integration of HPV were
found to coincide with the mutation of E2 gene [37, 38].
In addition, the disruption of E2 gene is reported as a
common and early event during the Cervical HPV infec-
tion [39]. Among the 8 viral fragments identified in our
study, half of them derived from E1 gene of HPV16, 2
derived from L2 gene, the remaining 2 viral elements
were found to origin from E2 and E5 gene respectively.
The C3-64:J-05-virus-left shared highest similarity with
the E2 gene of HPV16 isolate D15, with 3 nucleotides
mismatch and 2 nucleotides insertion. The 3-nucleotide
mismatches were expected to cause missense mutation
while the 2 nucleotides insertion would lead to frame-
shift mutation. Consequently, the functions of HPV E2
protein would be disrupted by those mutations. E1 en-
codes for a protein which binds to the viral origin of
replication, promoting the replication of viral genome.
We found 4 cases of HPV16 E1 gene integration coin-
ciding with extensive mutations, probably leading to the
disruption of the replication-promoting function of E1
gene. L1 was proposed to self-assemble into pentameric
capsomers and cooperate with L2 to package HPV DNA
into virion. The surface loops of L1 were found to vary
substantially even among members in the same papillo-
mavirus species, probably facilitating its evasion of
Fig. 1 Chromosome translocation events identified by sequencing in this study. The ideograms for the architectures of viral-cellular junctions (left)
and the location of fusion DNA on chromosomes (right) were shown for junctions S2-25:J-03 (a), S2-25:J-04 (b) and C5-87:J-08 (c) respectively. The
HPV16 viral fragment was shown in purple rectangle, cellular fragments were shown in orange or green rectangle. The gene structure of SCAI and
NR3C2 genes were shown in (a) below the ideogram of junction S2-25:J-03, the location of human fragment deriving from SCAI and NR3C2 genes
were shown as green and red arrow respectively
Zhao et al. Journal of Experimental & Clinical Cancer Research  (2016) 35:180 Page 6 of 14cellular immune responses [40]. We observed 2 cases of
HPV L1 integration, and viral protein mutation was
found in one of them (C4-77:J-06-virus-right). E5 pro-
tein is reported destabilize many membrane proteins in
HPV infected cells, probably preventing infected cell
from being wiping out by killer T cells. The C5-87:J-08-virus-right derived from E5 gene of HPV16, and no mu-
tation was detected in the inserted viral E5 element. In
summary, 1 case of un-mutated E5 gene (C5-87:J-08-
virus-right) and 1 case of un-mutated L1 gene fragment
(C5-87:J-07-virus-right) were found to be inserted into
cellular genome. 1 case of mutated L1 gene (C4-77:J-06-
Table 5 Overview of cancer related genes closely linked to HPV
integration sites documented in Dr.VIS v2.0 database [72]
ID Method Disease Subtype Cytoband Nearest gene
DRVIS03185 PCR HNC HPV16 1q25 TNFSF4
DRVIS03195 Exome-Seq CC HPV56 3q28 TP63
DRVIS03198 Mapping CC HPV16 1p36.32 TP73
DRVIS02845 RS-PCR CC HPV16 4q13.3 RASSF6
DRVIS00089 DIPS-PCR CC HPV16 2q21.2 ARHGEF4
DRVIS00246 DIPS-PCR CC HPV16 16q24 CDH13
The ID of integration events in Dr.VIS v2.0 database, methods for the detection
of viral integration, disease associated with samples, HPV subtype and
integration locations were shown in column 1, 2, 3, 4, 5 and 6 respectively.
HNC, head and neck cancer; CC, cervical carcinoma; Exome-Seq, Exome
sequencing; DIPS-PCR, detection of integrated papillomavirus sequences by
ligation-mediated PCR; RS-PCR, RNA Template-Specific PCR; Mapping, mapping
analysis. TNFSF4 (tumor necrosis factor superfamily member 4), TP63 (tumor
protein p63), TP73 (tumor protein p73), ARHGEF4 (Rho guanine nucleotide
exchange factor 4), CDH13 (cadherin 13), RASSF6 (Ras association domain family
member 6)
Fig. 2 The alignment between inserted viral elements (S1-2:J-01-F-01-virus-
sequences (HPV16 strain A24645 and HPV16 strain NC_001526.4). The “Que
sequences acquired from the NCBI database
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64:J-05-virus-left) and 4 cases of mutated E1 gene frag-
ments (S1-2:J-01-F-01-virus-left, S2-25:J-03-F-03-virus-
left, S2-25:J-04-virus-left and C3-64:J-05-virus-left) were
found to be integrated into host genome. Considering
that E1 protein promotes the replication of viral genome
and E2 protein negatively regulates the expression of
onco-gene. The integration and mutation of E1 and E2
genes would probably inhibit the viral DNA replication
while promoting viral onco-gene E6 and E7 expression.
The mutation of L1 might lead to the change in the anti-
genic epitope in the capsid of HPV16.
The HPV16 integration seem to occur around common
fragile sites through micro homology-mediated DNA
repair pathway
There is a heated debate regarding the integration mech-
anism of HPV. Some studies suggest that the HPV inte-
gration occurs at a random manner. However, more and
more evidence have been proposed to challenge thisleft and S2-25:J-03-F-03-virus-left) and most closely related HPV16
ry” indicates the viral sequences while the “sbjct” indicates the HPV16
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view on more than 190 reported HPV integration loci
and confirmed that HPV integration sites are distributed
over the chromosomes with a clear preference at gen-
omic fragile sites [41]. In a study on 47 HPV16 and
HPV18 positive cervical carcinoma, HPV were found to
integrate in a non-random manner, preferably to hot-
spots region [42, 43]. Similarly, a high throughput screen
on 3667 HPV integration breakpoints identified clus-
tered genomic hot spots and this study indicates that
HPV integration was likely to have occurred through mi-
cro homology-mediated DNA repair pathway, based on
the evidence that micro homologous sequence was sig-
nificantly enriched around integration sites [44]. In con-
sistent with previous finding that the HPV sequence are
more likely to integrate into the CFSs [43, 45]. In our re-
sults, among 8 integration sites identified, all of them oc-
curred near the CFSs. In particular, CFS FRA22B site
was affected twice. In addition, we observed short over-
lapping sequences between the viral and cellular frag-
ments in 8 out of 11 cases of virus-cell fusions among
the 8 junctions, and the overlapping DNA residuals
range from 2 nt to 6 nt. The observation that all the
HPV16 integration events occurred around CFSs com-
bined with the phenomena that short overlapping nucle-
otides existed between viral and celluar derived
fragments indicate that the fusion of HPV and cellular
fragments probably happened through micro homology-
mediated DNA repair pathway.
The effect of HPV integration on the expression of
cellular genes
After observing 3 cases of chromosome translocation,
we next asked what effect it would have on those genes
overlapped with integrating sites. Apparently, the gene
structure would be interrupted by such translocation
events. Taken SCAI and NR3C2 for instance, SCAI gene
is composed of 7 transcripts with the longest transcripts
having 18 exons and 17 introns. NR3C2 could be tran-
script into 8 mRNA isoforms with the longest one com-
posed of 9 exons and 8 introns. As the breakpoints was
located in the second intron of SCAI and the third in-
tron of NR3C2 genes. After translocation, SCAI would
lose its last 16 exons and NR3C2 would lose its first 3
exons. Therefore, the functions of both SCAI and
NR3C2 are expected to be largely disrupted, if not totally
abolished. In the other two translocation events, there
are no genes found to be directly overlapped with inte-
grating sites, however, the translocation would likely dis-
rupt the genes located nearby. Furthermore, the effects
of those translocation events will not be limited to re-
gions directly overlapped with or closely located. Instead,
translocation might affect the global interaction architec-
tures of translocated chromosomes. According to Hi-Cdata reported by Rao S, et al., there are extensive inter-
actions between DNA cis-regulatory elements inter- and
intra- chromosomes (Fig. 3) [14]. As the timing of gene
expression of target genes is largely determined by its
chromosome 3D architectures through epigenetic or
transcriptional regulation. It might be quite possible that
many master regulator genes and cell effectors genes will
be altered by such translocation. As the normal growth
of cells is controlled by a dedicated balance between on-
cogenes which promote cell proliferation and tumor
suppressor genes which repress cell growth, it would be
not surprising that the translocation between chromo-
somes could lead to substantial disruption to this bal-
ance and result in uncontrolled growth of cells.
In a systematic screen on more than 1500 integration
sites of HPV, Bodelon et al. found few integration events
happening in the neighborhood of cancer driver genes
[10]. In our study, we discovered several integration sites
located inside the introns of tumor suppressor genes (in-
cluding the famous SCAI gene), implying a link between
HPV integration and cervical oncogenesis, probably
through manipulating the expression of cancer related
genes. As introns are likely to accommodate multiple
binding sites of several transcription factors [46–52], the
integration of HPV would probably interrupt the original
expression patterns of affected genes either through the
introducing of novel transcription factors binding sites
(TFBSs) or the disruption of existing TFBSs which lo-
cated inside or around the breakpoints.
Peter, M. et al. performed a study on the HPV integra-
tion sites in 9 cell lines and found that HPV16 or 18 se-
quences were found to be integrated at chromosome 8q24,
the location of proto-oncogeneMYC. TheMYC gene alter-
ation and viral insertion were observed at the MYC locus
in vivo in primary tumors [53]. Previous study suggests
that HPV integration, even in intron regions, could affect
gene expression and contribute to the complete loss of
gene function in some occasions [54, 55]. In our study, the
integration of HPV16 in genes have been identified in the
introns of 4 genes (SNX25, KALRN, NAALADL2 and
CDH13) without chromosome translocation. Although the
HPV16 integration would not disrupt the structures of
exons, there might be quite a lot of cis regulatory elements
such as enhancers or insulators located in intron regions,
and the insertion of viral fragment would disrupt the inter-
action between TFs and cis regulatory elements and block
the chromosome interactions. Therefore, the HPV16 inte-
gration without chromosome translocation would also
affect the expression level of corresponding genes though
the coding sequences might still keep intact. Overall, the
impact of HPV16 integration could be profound and ex-
tensive. It would not only alter the expression of overlap-
ping and nearby genes, but also reshape the architecture
landscapes of affected chromosomes.
Fig. 3 The Hi-C data showing that there are intensive chromosome interactions around chromosome regions within 3225000 bp of 6 HPV16
integrating sites corresponding to 3 chromosome translocation events (a-f) at the resolution of 25,000 bp. Hi-C data of GM12878 cell line was
downloaded from the Interactive Hi-C Data Browser (http://promoter.bx.psu.edu/hi-c/) based on work of Rao, S. S. P. et al. [13]. The strengths of
interaction between different genome regions are positively correlated to the red color (deep red for interaction score > =500, white for
interaction score < =0)
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development through disruption tumor suppressor genes
and inducing chromosome instability
Hanahan, D. & Weinberg, R. A suggest that there are 8
hallmarks of human cancer: the sustaining of prolifera-
tive signal, the evasion of growth suppressing, the resist-
ing to cell death, the promoting of replication
immortality, the inducing of angiogenesis process, the
activating of metastasis, the reprogramming of energy
metabolism process and the evading of immune destruc-
tion [56]. In our study, the integration of HPV16 seems
to be linked to several those hallmarks, the sustaining of
proliferative signal, the evasion of growth suppressing
and immune destruction.
In our study, the integration of HPV16 combined with
translocation is expected to disrupt the function of
tumor suppresser gene SCAI. As a well-studied genes
which have been shown to negatively regulate Rho pro-
tein signal transduction. Rho proteins play important
roles in signal transduction which result in cytoskeletal-
dependent responses such as cell migration and phago-
cytosis. Besides, Rho proteins are important regulatorsof matrix-degrading proteases which are crucial to can-
cer invasion [57]. Thus the disruption of SCAI gene
would abolish its repression on Rho protein mediated
signal transduction and lead to the facilitating of cell mi-
gration, which contribute substantially to the metastasis
of tumor. In consistent with this hypothesis, Brandt, D.
T. et al. proposed that SCAI regulates the migration of
invasive cells via cell matrices based on the observation
that the expression level of SCAI was negatively corre-
lated with the degree of invasive cell migration, and
SCAI was found to be down regulated in several human
tumours [58]. Camilla Kreßner found that the expression
of SCAI diminished in a variety of primary human breast
cancer samples [59].
Based on the GO annotation of Kalirin protein
(O60229) in UniProt database [60], it was predicted
to involve in positive regulation of apoptotic process
which triggers the apoptotic death of a cell
(GO:0043065). It was also predicted to regulates Rho
protein signal transduction (GO:0035023), which leads
to cytoskeletal-dependent responses such as cell mi-
gration [57]. Therefore, Kalirin might be related to
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and escape apoptosis.
Sorting nexin 25 gene (SNX25) is also a cancer related
gene, which is localized in the cytoplasm and could
affect membrane association. SNX25 gene has the
phosphatidylinositol binding and type I transforming
growth factor beta receptor binding activity according
to its GO annotation. It also has signal transducer ac-
tivity (GO: 0004871). SNX25 is reported to be able to
negative regulate transforming growth factor beta re-
ceptor signaling pathway. In addition, SNX25 was re-
ported to regulate TGF-β signaling through enhancing
the receptor degradation [61].
N-acetyl-l-aspartyl-l-glutamate peptidase-like 2 (NAA-
LADL2) belongs to glutamate carboxypeptidase II family,
NAALADL2 has been reported to localize to the basal
cell surface and affect the adhesion, migration and inva-
sion of tumor cells. In addition, NAALADL2 also
regulate the expression of master regulator (Ser133
phosphorylated C-AMP-binding protein) of cellular pro-
cesses involved in the development and progression of
cancer [62].
Cadherin 13 (CDH13) gene encodes cadherin cellular
adhesion molecular, which localized to the cell mem-
brane surface. CDH13 is related to ERK Signaling andFig. 4 Interaction network of 6 proteins (SNX25, SCAI, KALRN, NAALADL2, C
HPV16 integration sites. The protein-protein interaction networks were dowNanog pathway, and its GO annotations include ‘cal-
cium ion binding and cadherin binding’. The expres-
sion level of CDH13 was found to be significantly
reduced in breast cancer specimen and breast carcin-
oma cell lines [63].
In addition to inferring the potential biological effects
posed by HPV16 integration on those overlapping genes,
we also analyzed the protein-protein interaction network
of those 6 proteins (SNX25, SCAI, KALRN, NAA-
LADL2, CDH13 and NR3C2) based on the interaction
relationships annotated in STRING database [13]. It in-
dicates that those 6 proteins interact with several effec-
tors or master regulators, involving in a variety of
pathways or biological processes (Fig. 4). Therefore, the
disruption of those 6 proteins would undermine those
protein-protein interaction relationships and interrupt
the pathways and biological functions regulated by those
proteins.
Genomic instability is a common characteristic shared
by most cancers [64–66]. Previous studies suggest that
human chromosomal instability or insertion mutagenesis
by integrated viral sequences may damage the key hot-
spots oncology-related genes and cause the structural
and numerical chromosome changes [67–69]. In our
study, we only observed three cases of chromosomeDH13 and NR3C2) encoded by genes directly overlapping with 8
nloaded from STRING database [13]
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However, we assume there are other chromosome varia-
tions such as genome insertion/deletion, gene copy
number variation though they were impossible to be ob-
served by us as we only focused on investigation to
study the integration of HPV16 into human genome and
the subsequent fusion between viral genome fragment
and cellular fragment. Nevertheless, we need to point
out that the chromosome translocation we observed is
just the tip of the iceberg, which serves a good indicator
of chromosome instability at genomic level. The obser-
vation that genes around HPV16 integrating sites are
enriched in GO terms associated with DNA repair is
particularly interesting. If the expression level of DNA
repair genes were affected by HPV16 integration. Then
we would expect to see accelerated genome instability
due to lacking of repaired for damaged or mutated
DNA. Therefore, we could deduce that HPV16 integra-
tion is likely to result in chromosome instability by com-
bining two pieces of independent evidence: the
chromosome translocation events around HPV16 inte-
grating sites, and the enrichment of DNA repair genes
within 10 Mb of HPV integrating sites.Fig. 5 HPV16 integration probably contributes to tumor progression throu
chromosome instabilityIntriguingly, we also observed the enrichment of im-
mune related genes (GO: 0071346 cellular response to
interferon-gamma and GO:0034341 response to
interferon-gamma) around HPV16 integrating sites.
Interferon-gamma has been reported to be a cytokine
that promotes both innate and adaptive immune re-
sponses. As a crucial immune response modifier which
could upregulate immune destruction against tumor, the
integration by HPV16 might undermine its protection
against cancer development and tumor immunoediting
[38]. In addition, GO: 0002548 monocyte chemotaxis’ is
also found to be enriched. Considering that chemotaxis
of tumor cells is essential for tumor dissemination dur-
ing the process of tumor progression and metastasis
[70], we are tempted to predict that HPV16 integration
might affect the migration and metastasis of tumor cells.
Previous reports suggest that the main function of HPV
integration is to stabilize the expression of viral oncogenes
instead of disruption of cellular genes [71]. However, our
study suggest that manipulating the expression of cellular
genes, especially cancer related genes, and inducing
chromosome instability might play much more significant
roles for the progress from lesions to invasive cancers thangh disrupting tumor suppressor gene expression and inducing
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Cancer related genes, especially tumor suppressor genes
were integrated by HPV16 and combined. 2) Genes dir-
ectly overlapping with HPV16 integration sites were
known or predicted to involve in a variety of biological
processes regarding the adhesions, apoptosis, prolifera-
tion, migration, immune evasion of tumor cells. 3) The
genes around HPV16 integrations sites were enriched in
GO terms related to the immune response, DNA repair,
tumor migration and the transfer of genetic materials. 4)
There were extensive chromosome interactions in regions
around HPV16 integrating sites. 5) Chromosome trans-
location events around HPV16 integration sites were de-
tected through sequencing, which indicates there might
exist widespread genomic variations induced by HPV16
integration. Taken together, our study suggests that
HPV16 integration probably contributes to tumor devel-
opment, through disruption tumor repressor genes and
inducing chromosome instability (Fig. 5).
Conclusion
In the current work, we focus on integration sites analysis
of HPV16, the most common type of HPV in Shanghai, try-
ing to understand the HPV16 integration characteristics
and the potential consequence of viral fragment integration.
We found that 8 HPV16 integration sites inside or around
genes associated with cancer development. On top of that,
we observed several cases of chromosome translocation
events coincide with HPV integration, which suggests the
existence of chromosome instability. Additionally, short
overlapping sequences were observed between viral derived
and host derived fragments in viral-cellular junctions, indi-
cating that integration was mediated by micro homology-
mediated DNA repair pathway. Overall, our study suggests
a model in which HPV16 might contribute to oncogenesis
not only by disrupting tumor suppressor genes, but also by
inducing chromosome instability. Nevertheless, it should be
noted that our hypothesis is simply based on the analysis of
relatively a small amount of HPV16 positive samples, which
should be interpreted cautiously. Comprehensive analysis
on large scale HPV screening experiments needs to be con-
ducted to confirm this hypothesis.
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